Shrestha Angita, Sadeyen Jean-Remy, Iqbal Munir
The Pirbright Institute, Ash Road, Pirbright, Woking GU24 0NF, Surrey, UK.
Department of Zoology, University of Oxford, Oxford OX1 2JD, UK.
Vaccines (Basel). 2018 Nov 15;6(4):75. doi: 10.3390/vaccines6040075.
Avian viral diseases including avian influenza, Marek's disease and Newcastle disease are detrimental to economies around the world that depend on the poultry trade. A significant zoonotic threat is also posed by avian influenza viruses. Vaccination is an important and widely used method for controlling these poultry diseases. However, the current vaccines do not provide full protection or sterile immunity. Hence, there is a need to develop improved vaccines. The major aim of developing improved vaccines is to induce strong and specific humoral and cellular immunity in vaccinated animals. One strategy used to enhance the immunogenicity of vaccines is the selective delivery of protective antigens to antigen-presenting cells (APCs) including dendritic cells, macrophages and B cells. APCs have a central role in the initiation and maintenance of immune responses through their ability to capture, process and present antigens to T and B cells. Vaccine technology that selectively targets APCs has been achieved by coupling antigens to monoclonal antibodies or ligands that are targeted by APCs. The aim of this review is to discuss existing strategies of selective delivery of antigens to APCs for effective vaccine development in poultry.
包括禽流感、马立克氏病和新城疫在内的禽类病毒性疾病对依赖家禽贸易的全球经济有害。禽流感病毒还构成重大的人畜共患病威胁。疫苗接种是控制这些家禽疾病的一种重要且广泛使用的方法。然而,目前的疫苗并不能提供完全保护或无菌免疫。因此,有必要开发改进的疫苗。开发改进疫苗的主要目的是在接种疫苗的动物中诱导强烈而特异性的体液免疫和细胞免疫。用于增强疫苗免疫原性的一种策略是将保护性抗原选择性递送至包括树突状细胞、巨噬细胞和B细胞在内的抗原呈递细胞(APC)。APC通过其捕获、处理抗原并将抗原呈递给T细胞和B细胞的能力,在免疫反应的启动和维持中发挥核心作用。通过将抗原与APC靶向的单克隆抗体或配体偶联,已实现了选择性靶向APC的疫苗技术。本综述的目的是讨论将抗原选择性递送至APC以有效开发家禽疫苗的现有策略。